Mykyta Artomov
Principal Investigator
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (17)
Year:
2025
An active module in biological graphs is a connected subgraph whose vertices share a common biological function. To identify an active module, one must first construct a weighted biological graph. The weight of each vertex is calculated based on biological experiments investigating the target biological function. However, the results of a single experiment may not fully describe the desired active module, covering only part of it and potentially introducing uncertainty into the vertex weights. This work demonstrates that employing Fisher’s method to integrate data from multiple experiments followed by applying a Markov chain Monte Carlo (MCMC) and machine learning–based approach to the results of Fisher’s method, enables more effective identification of active modules in biological graphs. The study utilizes the InWebIM protein–protein interaction graph, a human brain reconstruction graph from the BigBrain project, and a gene graph for the organism Caenorhabditis elegans. To combine the results of several experiments into a single outcome within one graph, Fisher’s method is applied. Afterwards, the search for active modules is conducted using an MCMC and machine learning-based method. To validate the proposed method on real data, results from GenomeWide Association Studies on schizophrenia and smoking are used, along with the gene expression matrix of patients with skin melanoma from the TCGA project. Applying Fisher’s method makes it possible to consider the results of multiple biological experiments simultaneously. Subsequent use of the MCMC and machine learning–based method improves the accuracy of identifying active modules compared to ranking graph vertices solely by Fisher’s method. Considering the results of multiple biological experiments when determining active modules plays a crucial role in increasing the accuracy of identifying the vertices of the active module. This, in turn, promotes a deeper understanding of the biological mechanisms of diseases, which can be of great significance for the development of new diagnostic and therapeutic methods.
Year:
2025
Year:
2025
Aim. To evaluate the features of antihypertensive therapy (AHT), adherence to therapy and achievement of target blood pressure (BP) in patients with hypertension (HTN) in Russian real-world practice after the implementation of 2024 Russian clinical guidelines on hypertension in adults. Material and methods. During May 2025, 7990 patients with HTN from 19 Russian cities and Tiraspol (Pridnestrovian Moldavian Republic) took part in the BP measurement campaign. Outpatients with HTN over the age of 18 voluntarily participated in the campaign. During the screening, BP and pulse were measured three times using an automatic or mechanical BP monitor. In addition, a questionnaire was filled out on behavioral risk factors, BP self-monitoring skills, medication adherence, AHT, comorbidities and related therapy. The effectiveness of AHT was understood as achieving the target BP level <140/90 mm Hg in patients with HTN and taking AHT, and BP control — in all hypertensive patients, regardless of taking AHT. Results. The analysis included 7972 respondents aged 18 to 96 years (median age 62 years [51;71]), including 3372 men (42,3%). Among the participants, 74,4% took AHT, while 62,6% achieved target BP <140/90 mm Hg and 25,8% — target BP <130/80 mm Hg. On-demand therapy remains the leading reason for not taking AHT among patients with HTN. Approximately half of the participants (57,7%) answered that they do not use medication reminder systems. Most often, hypertensive patients use BP self-monitoring diaries and pill boxes. Every fifth patient with HTN was registered as taking antihypertensive monotherapy, every third as dual AHT, and every fourth as triple AHT. Single-pill combinations were taken by 34,5% of patients. In outpatient practice, following sex differences were revealed: significantly higher prevalence of taking AHT, using AHT reminder systems, discussions with a doctor, and the effectiveness of treatment and control of HTN were characteristic of female patients. Discussion with a doctor about the importance of following recommendations was associated with a significantly higher achievement of target BP level (odds ratio (OR) 1,43), the use of a single-pill AHT combination (OR 1,3) and statin therapy (OR 1,39), p<0,0001. Conclusion. In outpatient practice after the implementation of 2024 Russian clinical guidelines for HTN, an increase in the coverage and efficacy of AHT, and the HTN control is observed compared to the population data of 2020-2022. AHT prescription profile indicates a decrease in the share of monotherapy and an increase in the share of triple combination. The use of single-pill antihypertensive combinations is growing, but remains insufficient. The results obtained demonstrate the importance of discussing with a physician the need to comply with recommendations in hypertensive patients to improve adherence and treatment effectiveness.
Year:
2025
Suicide is a major cause of death worldwide, yet pharmacological options for alleviating suicidality remain limited. Clozapine and ketamine are among the few small molecules with well-documented anti-suicidal effects, direct evidence linking their molecular activity to the genetics of suicide has been scarce. In this study, we conducted a transcriptome-wide association analysis of suicide phenotypes in the prefrontal cortex (Brodmann area 9) of 172 patients with major depressive disorder (MDD). This allowed us to define genetic signatures associated with suicidal behavior. We then inverted these signatures and, using SigCom LINCS L1000 consensus signatures, ranked small molecules by the similarity of their induced expression changes. Both ketamine and clozapine were significantly prioritized in this analysis. Further examination at the individual-gene level revealed that the prioritization of these two compounds was driven by the downregulation of insulin receptor substrate 2 ( IRS2 ), a key mediator of IGF-1 and insulin signaling. In line with this finding, compounds known to upregulate IRS2 - such as IGF-1 inhibitors, glucocorticoid agonists, and PI3K and MTOR inhibitors - showed negative enrichment in the prioritization. These observations suggest a common mechanistic link between the transcriptional responses to ketamine and clozapine and the genetic signatures associated with suicide in MDD.
Year:
2025
Year:
2024
Computational tools for predicting variant pathogenicity are widely used to support clinical variant interpretation. Recently, several models, which do not rely on known variant classifications during training, have been developed. These approaches can potentially overcome biases of current clinical databases, such as misclassifications, and can potentially better generalize to novel, unclassified variants. AlphaMissense is one such model, built on the highly successful protein structure prediction model, AlphaFold. AlphaMissense has shown great performance in benchmarks of functional and clinical data, outperforming many supervised models that were trained on similar data. However, like other in silico predictors, AlphaMissense has notable limitations. As a large deep learning model, it lacks interpretability, does not assess the functional impact of variants, and provides pathogenicity scores that are not disease specific. Improving interpretability and precision in computational tools for variant interpretation remains a promising area for advancing clinical genetics.
Year:
2024
With the increase in life expectancy, there is an increase in the number of elderly people among the population, therefore, an important task for Russian health care is to ensure healthy aging. An examination of a group of centenarians can help in studying the factors and causes that contribute to a long life without development or with the later development of age-associated diseases. In many ways, the long life expectancy and better health of such people are genetically determined. At the same time, longevity, as a complex sign, is influenced by many genetic polymorphisms, often with a small individual effect. Identification of hereditary determinants and their effects on the mechanisms of aging is necessary to identify the foundations of healthy longevity and to find protector mechanisms and targets by which it is possible to prevent the occurrence or slow the progression of age-related diseases. The pathology of the cardiovascular system is the most significant of the diseases associated with aging, since it is the leading cause of mortality according to world statistics. Thus, cardiovascular aging is an important factor in determining a person’s life expectancy. This article examines the methodological aspects of studies involving centenarians, and also provides an overview of genes that affect both life expectancy and longevity, as well as the development and course of cardiovascular diseases.
Year:
2024
Acquiring a sufficiently powered cohort of control samples matched to a case sample can be time-consuming or, in some cases, impossible. Accordingly, an ability to leverage genetic data from control samples that were already collected elsewhere could dramatically improve power in genetic association studies. Sharing of control samples can pose significant challenges, since most human genetic data are subject to strict sharing regulations. Here, using the properties of singular value decomposition and subsampling algorithm, we developed a method allowing selection of the best-matching controls in an external pool of samples compliant with personal data protection and eliminating the need for genotype sharing. We provide access to a library of 39,472 exome sequencing controls at http://dnascore.net enabling association studies for case cohorts lacking control subjects. Using this approach, control sets can be selected from this online library with a prespecified matching accuracy, ensuring well-calibrated association analysis for both rare and common variants.
Year:
2024
The high prevalence of autoimmune hypothyroidism (AIHT) - more than 5% in human populations - provides a unique opportunity to unlock the most complete picture to date of genetic loci that underlie systemic and organ-specific autoimmunity. Using a meta-analysis of 81,718 AIHT cases in FinnGen and the UK Biobank, we dissect associations along axes of thyroid dysfunction and autoimmunity. This largest-to-date scan of hypothyroidism identifies 418 independent associations (p 0.95) with the lead SNP at the locus, including low-frequency coding variants at LAG3 , ZAP70 , TG, TNFSF11, IRF3, S1PR4, HABP2, ZNF429 as well as established variants at ADCY7, IFIH1 and TYK2 . The variants at LAG3 (P67T), ZAP70 (T155M), and TG (Q655X) are highly enriched in Finland and functional experiments in T-cells demonstrate that the ZAP70 :T155M allele reduces T-cell activation. By employing a large-scale scan of non-thyroid autoimmunity and a published meta-analysis of TSH levels, we use a Bayesian classifier to dissect the associated loci into distinct groupings and from this estimate, a significant proportion are involved in systemic (i.e., general to multiple autoimmune conditions) autoimmunity (34%) and another subset in thyroid-specific dysfunction (17%). By comparing these association results further to other common disease endpoints, we identify a noteworthy overlap with skin cancer, with 10% of AIHT loci showing a consistent but opposite pattern of association where alleles that increase the risk of hypothyroidism have protective effects for skin cancer. The association results, including genes encoding checkpoint inhibitors and other genes affecting protein levels of PD1, bolster the causal role of natural variation in autoimmunity influencing cancer outcomes.
Year:
2024
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Year:
2023
Collaborators (6)
Matti Pirinen
University of Helsinki
Tiinamaija Tuomi
Professor
University of Helsinki
Aarno Palotie
University of Helsinki
Elizabeth Atkinson
Assistant Professor
Baylor College of Medicine
Samuli Ripatti
University of Helsinki
Jukka Partanen
Research Director, Professor
University of Helsinki
Make your next move.
Prepare your application
Review drafts before you send them.